Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPERNICUS: VEGF Trap-Eye in Macular Edema Secondary to CRVO
NCT00943072Phase 3Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Jul 2009
- Primary completion
- Oct 2010
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 5
01
Overview
A Phase 3 trial of aflibercept in macular edema, sponsored by Regeneron Pharmaceuticals. Started Jul 2009; status: completed.
02
Drugs
aflibercept
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT00943072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00943072.